Detalles de la búsqueda
1.
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
FASEB J
; 27(10): 4279-93, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23884428
2.
Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.
Oncol Rep
; 32(1): 419-24, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24841903
3.
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.
Cancer Biol Ther
; 14(5): 401-10, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23377825
Resultados
1 -
3
de 3
1
Próxima >
>>